Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide
Damien Mailhol(Max-Planck-Institut für Kohlenforschung), Alois Fürstner(Max-Planck-Institut für Kohlenforschung), Elizabeth Rubitski(Pfizer (United States)), Sylvia Musto(Pfizer (United States)), Andreas Maderna(Pfizer (United States)), Jens Willwacher(Max-Planck-Institut für Kohlenforschung), My‐Hanh Lam(Pfizer (United States)), Frank Loganzo(Pfizer (United States)), Zhanna Sobol(Pfizer (United States)), Maik Schuler(Pfizer (United States)), Nina Kausch‐Busies(Max-Planck-Institut für Kohlenforschung)
Cited by 93
Related Papers
Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2006|131
Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells
|Mutation Research Letters|1995|119
Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2010|106
A critical evaluation of centromeric labeling to distinguish micronuclei induced by chromosomal loss and breakage in vitro
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|1997|89
Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay
|Environmental and Molecular Mutagenesis|2017|74